Table 1.

Completeness of TNM registration for 3658 patients with small cell lung cancer according to year of diagnosis, gender, age, and level of comorbidity

	TNM completeness		T completeness		N completeness		M completeness		Total
	% (N)	95% CI	% (N)	95% CI	% (N)	95% CI	% (N)	95% CI	N
Year of diagnosis
2004	75.9 (421)	72.2–79.3	87.7 (487)	84.8–90.3	80.9 (449)	77.5–84.0	92.6 (514)	90.2–94.6	555
2005	76.0 (469)	72.5–79.3	85.7 (529)	82.8–88.3	81.5 (503)	78.3–84.4	92.2 (569)	89.9–94.1	617
2006	75.5 (468)	72.0–78.8	85.5 (530)	82.6–88.1	81.6 (506)	78.4–84.5	91.9 (570)	89.6–93.9	620
2007	75.3 (484)	71.8–78.5	84.6 (544)	81.7–87.2	80.7 (519)	77.5–83.6	92.4 (594)	90.1–94.2	643
2008	78.7 (474)	75.3–81.9	90.4 (544)	87.8–92.5	85.4 (514)	82.4–88.0	93.5 (563)	91.3–95.3	602
2009	83.4 (518)	80.3–86.2	91.0 (565)	88.5–93.1	89.0 (553)	86.4–91.3	95.8 (595)	94.0–97.2	621
Gender
Female	76.9 (1359)	74.9–78.8	87.5 (1546)	85.9–89.0	83.1 (1468)	81.3–84.8	92.5 (1635)	91.2–93.7	1767
Male	78.0 (1475)	76.1–79.8	87.4 (1653)	86.0–88.9	83.3 (1576)	81.6–85.0	93.6 (1770)	92.4–94.6	1891
Age
0–39 years	85.7 (6)	49.9–98.4	100 (7)	70.8–100	85.7 (6)	49.9–98.4	100 (7)	70.8–100	7
40–59 years	78.7 (548)	75.6–81.7	88.2 (614)	85.7–90.5	83.6 (582)	80.7–86.2	95.5 (665)	93.8–96.9	696
60–79 years	78.5 (2043)	76.9–80.1	88.0 (2290)	86.7–89.2	84.2 (2192)	82.8–85.6	93.7 (2437)	92.7–94.6	2602
≥80 years	67.1 (237)	62.1–71.9	81.6 (288)	77.3–85.4	74.8 (264)	70.1–79.1	83.9 (296)	79.8–87.4	353
Level of comorbidity
0	80.5 (1576)	78.7–82.2	89.7 (1755)	88.3–91.0	85.6 (1675)	84.0–87.1	94.7 (1854)	93.7–95.7	1957
1–2	75.6 (961)	73.2–77.9	86.5 (1099)	84.5–88.3	81.7 (1038)	79.5–83.7	92.0 (1169)	90.4–93.4	1271
≥3	69.1 (297)	64.6–73.3	80.2 (345)	76.3–83.8	77.0 (331)	72.8–80.8	88.8 (382)	85.6–91.6	430
Total	77.5 (2834)	76.1–78.8	87.5 (3199)	86.4–88.5	83.2 (3044)	82.0–84.4	93.1 (3405)	92.2–93.9	3658